Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Effectiveness of Prolonged Exposure of PTSD in a Community Setting of PTSD Sufferers
This study is not yet open for participant recruitment.
Verified by HaEmek Medical Center, Israel, August 2007
Sponsored by: HaEmek Medical Center, Israel
Information provided by: HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier: NCT00521768
  Purpose

Introduction: Efforts to bridge the gap between research based treatment modalities advancements and clinical practice have received the highest priority in the research community. In the child psychiatry field there is an urging need to promote bridging this gap.

Parents and child health providers hesitate to refer children to child psychiatrist due to stigma but also due to lack of awareness of available and efficient treatment options. In the field of trauma treatment another reason for lack of treatment is lack of recognition of trauma related symptoms in children.

After the second Lebanon war scarce referrals to psychiatric clinics have been registered and access to treatment is low as indicated by 20 referrals in the past year to Emek Hospital.

We propose to explore the effectiveness of well-established adult treatment for PTSD, the Prolonged Exposure (PE), in community-based general pediatric clinics, serving an underprivileged diverse population.

Methods:

Twenty children age 6 to 18 attending general pediatric clinic and in Afula region will included.

children will be diagnosed using the Hebrew translation of the Childhood version of the Schedule for Affective Disorders and Schizophrenia (Apter et al., 1989 Children will receive the Children's Depression Inventory (CDI) and the. CPSS All subjects will be treated with a manualized 12-week Prolonged Exposure protocol Ratings will be made at baseline, 6weeks, and 12 weeks using CDI and CPSS

Hypothesis:

1. PE adapted for pediatric population will be effective in treating single-event traumas in a community setting.


Condition Intervention
Post Traumatic Stress Disorder
Anxiety Disorder
Behavioral: Prolonged exposure

MedlinePlus related topics: Anxiety Post-Traumatic Stress Disorder
U.S. FDA Resources
Study Type: Interventional
Study Design: Diagnostic, Open Label, Uncontrolled, Single Group Assignment

Further study details as provided by HaEmek Medical Center, Israel:

Primary Outcome Measures:
  • CDI questionaire [ Time Frame: 12 weeks ]

Estimated Enrollment: 20
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   6 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Children age 6 to 18
  • Language spoken: Hebrew
  • DSM- IV R diagnosis: PTSD
  • Anxiety disorder

Exclusion Criteria:

  • Children presenting with psychotic symptoms,
  • Children presenting with mental retardation
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00521768

Contacts
Contact: Ziva Bracha, MD 972-4-6494138 ext 4138 bracha_zi@clalit.org.il

Locations
Israel
HaEmek Medical Center - Psychiatry Department
Afula, Israel, 18101
Sponsors and Collaborators
HaEmek Medical Center, Israel
Investigators
Principal Investigator: Ziva Bracha, MD HaEmek MC
  More Information

Study ID Numbers: CT20
Study First Received: August 27, 2007
Last Updated: August 27, 2007
ClinicalTrials.gov Identifier: NCT00521768  
Health Authority: Israel: Ministry of Health

Keywords provided by HaEmek Medical Center, Israel:
Post traumatic stress disorder
Anxiety disorder
Comunity base intervention
Education
Behavioural treatment

Study placed in the following topic categories:
Anxiety Disorders
Mental Disorders
Stress Disorders, Post-Traumatic
Stress
Stress Disorders, Traumatic

Additional relevant MeSH terms:
Pathologic Processes
Disease

ClinicalTrials.gov processed this record on January 16, 2009